NCT04900324 (MAUSBOT) is a NA clinical trial of MRI guidance in Mandibular Dysfunction, sponsored by Centre Hospitalier Universitaire de Besancon.

Who is sponsoring NCT04900324?

NCT04900324 is sponsored by Centre Hospitalier Universitaire de Besancon.

What drugs are being tested in NCT04900324?

Interventions in NCT04900324: MRI guidance, Ultrasound guidance.

What condition does NCT04900324 study?

NCT04900324 studies Mandibular Dysfunction.

Is NCT04900324 still recruiting?

NCT04900324 is currently terminated. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT04900324: MAUSBOT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intramuscular Injections of Botulinum Toxin in Lateral Pterygoid Muscle in the Treatment of Temporomandibular Dysfunctions: Studying the Interest of MRI Guidance and Ultrasound Guidance

Terminated NA Last updated 19 September 2024

What this trial tests

NA trial testing MRI guidance in Mandibular Dysfunction in 4 participants. Terminated before completion.

Timeline

13 September 2021

Primary endpoint
16 February 2024

16 February 2024

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Besancon
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	4
Start date	13 September 2021
Primary completion	16 February 2024
Estimated completion	16 February 2024
Sites	1 location across France

Drugs / interventions tested

MRI guidance
Ultrasound guidance

Conditions studied

Mandibular Dysfunction — all drugs for Mandibular Dysfunction →

Sponsor

Centre Hospitalier Universitaire de Besancon

Who can join

18 and older, any sex, with Mandibular Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main hypothesis is that a significant pain improve (measured with Visual Analogic Scale \[VAS\]) can be observed after injection of botulinum toxin A, meaning the success of the guidance device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Besancon trials

Trials by the same sponsor.

NCT07492199 — High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. · not yet recruiting
NCT07438015 — VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit · NA · not yet recruiting
NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
NCT07067762 — Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04900324 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04900324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing